R4 / now serving 12 enterprise research programs

AI infrastructure
for molecular discovery.

Train, simulate, and validate next-generation therapeutics with scalable biological intelligence. Helixion gives research teams a single computational surface across foundation models, simulation, and orchestration.

helixion · console
64×H200t+02:14:38 live
target
KRAS·G12C
conf 0.94 · 412 atoms
ΔG bind▲ 12%
−9.4kcal/mol
candidates18,422
gen-mol-22b · pruning by tox-net-v4step 03 of 06

Discovery still runs
on a 20th-century clock.

Wet-lab cycles, fragmented tooling, late toxicity, siloed data. Computational depth has been an accessory — never the substrate.

$2.6B
average cost to bring a single therapeutic to market
10⁶⁰
candidate molecules in relevant chemical space
0.001%
of that space ever assayed by any organization
12 yrs
median timeline from target identification to approval

Four primitives for
computational pharmacology.

Each module is independently deployable and composes through a single research API and shared molecular memory.

A · Generation

Molecular Generation Engine

Generate novel therapeutic candidates using molecular foundation models trained on billions of structures.

gen-mol-22b24,118 / batch
B · Simulation

Simulation Layer

Predict protein folding, binding affinity, and dynamic biological response across time-resolved trajectories.

C · Safety

Toxicity Intelligence

Forecast adverse effects, off-target interactions, and failure probabilities long before lab validation.

assayp(failure)
HEP-G2
0.04
hERG channel
0.12
CYP3A4 inhib.
0.31
AMES mutagen.
0.06
Cardiotox.
0.42
Nephrotox.
0.09
D · Orchestration

Research Orchestration

Coordinate datasets, experiments, models, and teams across a single computational research surface.

orchestrator

Dataset to deployed pipeline,
one continuous environment.

step / 01

Train Biological Models

Fine-tune molecular and protein foundation models on your proprietary datasets and structural libraries.

step / 02

Simulate Molecular Outcomes

Execute large-scale in-silico experiments across folding, binding, ADMET, and population response.

step / 03

Deploy Research Pipelines

Promote validated workflows into production, accessible to bench scientists through a single API.

Built like the rest of
your stack should be.

01 / API

Stable research API

REST and gRPC surfaces, streaming inference, batch endpoints — versioned and stable.

p99 latency
38ms
uptime
99.99%
endpoints
142
sdk
py · ts · r
02 / Compute

Secure enclaves

Isolated tenants, hardware-attested enclaves, end-to-end encrypted workloads.

  • SOC 2 Type II
  • HIPAA · BAA
  • GxP validation
  • EU residency
  • HSM-backed keys
  • VPC peering
03 / GPU

Orchestration

Elastic H200 / B200 pools, fair-share scheduling, transparent burst.

4,096max gpu
04 / Data

Dataset management

Proprietary structure libraries, lineage, dedup, access-controlled sharing.

4.2pb indexed
05 / Models

Versioning & promotion

Reproducible weights, eval suites, A/B promotion across environments. Rollback in seconds.

06 / Team

Collaborative research

Shared notebooks, comments, review workflows over live runs and datasets — team-scoped IAM + full audit trail.

83%
reduction in early-stage screening time
vs. internal wet-lab baseline, 14 cohort programs
10M+
molecular simulations processed
across foundation and assay-specific models
faster candidate validation
median time from target to lead series

A research terminal
for biotech AI.

Live model monitoring, experiment pipelines, computational clusters, and molecular memory — one surface, every layer.

helixion ~ research-terminalv4.2.1 · connected
Live model monitoring
[15:42:08] helix-fold-3b · batch 128 · throughput 4,212 seq/s
[15:42:09] gen-mol-22b · candidates +18,422
[15:42:10] tox-net-v4 · pruned 11,308 (61.4%)
[15:42:11] orchestrator · checkpoint persisted s3://hx-runs/1024
[15:42:12] ranking 7,114 survivors by affinity_

Build therapeutics at
computational scale.

Helixion partners directly with research-stage and enterprise programs. Access is granted by program review.